Beta Bionics Inc. (BBNX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Beta Bionics Inc.

    NASDAQ: BBNX · Real-Time Price · USD
    22.26
    1.77 (8.64%)
    At close: Oct 03, 2025, 3:59 PM
    22.26
    0.00%
    After-hours: Oct 03, 2025, 04:35 PM EDT

    Beta Bionics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 65.12M 11.99M 179K
    Cost of Revenue
    		 29.24M 5.69M n/a
    Gross Profit
    		 35.89M 6.31M 179K
    Operating Income
    		 -45.25M -35.85M -65.84M
    Interest Income
    		 3.91M n/a 196K
    Pretax Income
    		 -54.76M -44.1M -64.75M
    Net Income
    		 -54.76M -44.1M -64.75M
    Selling & General & Admin
    		 54.95M 24.21M 33.49M
    Research & Development
    		 26.18M 17.94M 31.43M
    Other Expenses
    		 n/a n/a 1.1M
    Operating Expenses
    		 81.14M 42.16M 66.02M
    Interest Expense
    		 n/a n/a 14K
    Selling & Marketing Expenses
    		 37.09M 11.99M 8.83M
    Cost & Expenses
    		 110.38M 47.84M 66.02M
    Income Tax Expense
    		 n/a n/a n/a
    Shares Outstanding (Basic)
    		 6.37M 5.3M 5M
    Shares Outstanding (Diluted)
    		 6.37M 5.3M 5M
    EPS (Basic)
    		 -8.6 -8.31 -12.96
    EPS (Diluted)
    		 -8.6 -8.31 -12.96
    EBITDA
    		 -44.1M -34.62M -63.4M
    EBIT
    		 -45.25M -35.85M -64.74M
    Depreciation & Amortization
    		 1.15M 1.23M 1.34M

    Add to Watchlist